Bachanova, Veronika http://orcid.org/0000-0002-9325-432X
Sarhan, Dhifaf
DeFor, Todd E.
Cooley, Sarah
Panoskaltsis-Mortari, Angela
Blazar, Bruce R.
Curtsinger, Julie M.
Burns, Linda
Weisdorf, Daniel J.
Miller, Jeffrey S.
Funding for this research was provided by:
National Institutes of Health (P30 CA77598)
National Center for Advancing Translational Sciences (UL1TR000114)
National Cancer Institute (P01 CA65493, P01 CA111412, R01 CA72669)
American Society of Hematology (ASH Scholar)
Article History
Received: 1 May 2017
Accepted: 24 November 2017
First Online: 7 December 2017
Compliance with ethical standards
:
: Eisai Inc has provided denileukin diftitox for this trial and supported the correlative assays. Veronika Bachanova receives funding from GT Biopharma Inc, Novartis and serves on advisory board for Seattle-Genetics. Other authors have no relevant conflicts of interest to report. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.